Latest News

Investigational PrimeC Improves Complication-Free Survival in PARADIGM Study of ALS
Investigational PrimeC Improves Complication-Free Survival in PARADIGM Study of ALS

July 13th 2024

Following the positive data, NeuroSense intends to submit 12-month results to the FDA for regulatory discussions on future path.

NeurologyLive® Friday 5 — July 12, 2024
NeurologyLive® Friday 5 — July 12, 2024

July 12th 2024

Lomecel-B Becomes First Agent to Gain Regenerative Medicine Advanced Therapy Designation for Alzheimer Disease
Lomecel-B Becomes First Agent to Gain Regenerative Medicine Advanced Therapy Designation for Alzheimer Disease

July 12th 2024

Episode 119: Utilizing the Syn-One Test to Diagnose Parkinson Disease
Episode 119: Utilizing the Syn-One Test to Diagnose Parkinson Disease

July 12th 2024

CMSC’s Clinician Guide to the 2021 Consensus Recommendations on MRI Use in Multiple Sclerosis
CMSC’s Clinician Guide to the 2021 Consensus Recommendations on MRI Use in Multiple Sclerosis

July 11th 2024

Coverage of the Third Annual Advanced Therapeutics in Movement & Related Disorders Congress

Get the latest data and clinical news updates, as well as interviews with experts, straight from the conference floor of the ATMRD Congress.

ATMRD 2024

Conference Coverage

View All
Overviewing the XYLO Study and Low-Sodium Oxybate’s Impact on Blood Pressure: Phil Jochelson
Overviewing the XYLO Study and Low-Sodium Oxybate’s Impact on Blood Pressure: Phil Jochelson

July 12th 2024

Future Research Efforts in Aging MS
Future Research Efforts in Aging MS

July 11th 2024

Understanding Epigenetic and Biologic Aging in Multiple Sclerosis
Understanding Epigenetic and Biologic Aging in Multiple Sclerosis

July 11th 2024

Charbel Moussa, MBBS, PhD
Advances in Multifaceted Drug Approaches for Dementia in Movement Disorders: Charbel Moussa, MBBS, PhD

July 10th 2024

Video Series
Video Interviews
Podcasts

Most Recent

© 2024 MJH Life Sciences

All rights reserved.